Azelby Robert
Insider CIK 1656998 · CASC Director · ALDR President and CEO, Director · KDNY Director · CLVS Director · JUNO See Remarks · AUTL Director · ELYM President & CEO, Director · ADCT Director · TNGX Director · TERN Director · CAH Director · IMMU Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics plc | A Award deriv | 2026-06-29 | 2026-07-01 | 47,500 | — | $0 | 47,500 | SEC↗ |
| AUTL Autolus Therapeutics plc | A Award deriv | 2026-06-29 | 2026-07-01 | 31,667 | — | $0 | 31,667 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2026-06-19 | 2026-06-23 | 35,910 | — | $0 | 35,910 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2026-06-19 | 2026-06-23 | 5,740 | — | $0 | 5,740 | SEC↗ |
| ADCT ADC Therapeutics SA | F Tax w/h | 2026-06-03 | 2026-06-03 | 12,600 | $3.08 | $38.8K | 112,805 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award | 2026-06-01 | 2026-06-03 | 45,000 | — | $0 | 125,405 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 90,000 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 1,697 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2026-02-01 | 2026-02-02 | 1,697 | — | $0 | 1,697 | SEC↗ |
| CAH CARDINAL HEALTH INC | A Award | 2025-11-05 | 2025-11-06 | 1,067 | — | $0 | 4,085 | SEC↗ |
| ADCT ADC Therapeutics SA | F Tax w/h | 2025-06-13 | 2025-06-17 | 12,600 | $3.58 | $45.1K | 80,405 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award | 2025-06-03 | 2025-06-05 | 40,000 | — | $0 | 93,005 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2025-02-20 | 2025-02-24 | 90,000 | — | $0 | 90,000 | SEC↗ |
| CAH CARDINAL HEALTH INC | A Award | 2024-11-06 | 2024-11-07 | 1,730 | — | $0 | 3,018 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2024-06-17 | 2024-06-18 | 6,995 | $2.89 | $20.2K | 53,005 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award | 2024-06-13 | 2024-06-14 | 40,000 | — | $0 | 60,000 | SEC↗ |
| CAH CARDINAL HEALTH INC | A Award | 2024-03-15 | 2024-03-18 | 1,288 | — | $0 | 1,288 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 7,000 | — | $0 | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 28,200 | $18.40 | $518.9K | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2023-04-10 | 2023-04-12 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2023-04-10 | 2023-04-12 | 28,200 | — | $0 | 28,200 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2022-10-31 | 2022-11-02 | 500,000 | — | $0 | 500,000 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2022-01-27 | 2022-01-31 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 42,223 | — | $0 | 42,223 | SEC↗ |
| IMMU IMMUNOMEDICS INC | D To issuer deriv | 2020-10-23 | 2020-10-23 | 3,718 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | D To issuer deriv | 2020-10-23 | 2020-10-23 | 29,040 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2020-06-18 | 2020-06-22 | 6,540 | — | $0 | 6,540 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award | 2020-06-18 | 2020-06-22 | 3,718 | — | $0 | 3,718 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2020-06-04 | 2020-06-05 | 40,138 | — | $0 | 40,138 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2020-02-26 | 2020-02-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | D To issuer deriv | 2019-10-22 | 2019-10-24 | 150,000 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | D To issuer deriv | 2019-10-22 | 2019-10-24 | 15,000 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | D To issuer deriv | 2019-10-22 | 2019-10-24 | 1,000,000 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | D To issuer deriv | 2019-10-22 | 2019-10-24 | 505,000 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2019-06-06 | 2019-06-07 | 28,882 | — | $0 | 28,882 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2019-04-23 | 2019-04-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2019-02-06 | 2019-02-08 | 505,000 | — | $0 | 505,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2019-02-06 | 2019-02-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2018-10-11 | 2018-10-15 | 25,848 | — | $0 | 25,848 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2018-06-13 | 2018-06-15 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 13,927 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 12,437 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 98,545 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 93,294 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 30,002 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 7,500 | — | $0 | 82,112 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 20,580 | — | $0 | 61,532 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 25,639 | — | $0 | 35,893 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 35,893 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2018-02-12 | 2018-02-14 | 4,157 | $85.55 | $355.6K | 89,614 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2018-02-12 | 2018-02-15 | 4,159 | $85.55 | $355.8K | 89,612 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2018-02-08 | 2018-02-09 | 2,663 | — | $0 | 98,545 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2018-02-08 | 2018-02-09 | 834 | — | $0 | 30,002 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2018-02-08 | 2018-02-09 | 834 | $25.29 | $21.1K | 94,605 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2018-02-08 | 2018-02-09 | 2,663 | $20.76 | $55.3K | 97,268 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2018-02-08 | 2018-02-09 | 3,497 | $85.77 | $299.9K | 93,771 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | F Tax w/h | 2018-02-07 | 2018-02-09 | 2,700 | $85.49 | $230.8K | 93,771 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2018-02-01 | 2018-02-02 | 4,167 | — | $0 | 93,294 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2018-02-01 | 2018-02-02 | 4,167 | $51.76 | $215.7K | 100,638 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2018-02-01 | 2018-02-02 | 4,167 | $85.78 | $357.4K | 96,471 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2018-01-31 | 2018-02-02 | 25,639 | — | $0 | 96,471 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2018-01-22 | 2018-01-24 | 102,539 | — | $0 | 97,461 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2018-01-22 | 2018-01-24 | 102,539 | $51.76 | $5.31M | 173,371 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2018-01-22 | 2018-01-24 | 102,539 | $86.25 | $8.84M | 70,832 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2018-01-17 | 2018-01-19 | 26,633 | — | $0 | 101,208 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2018-01-17 | 2018-01-19 | 2,498 | — | $0 | 30,836 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2018-01-17 | 2018-01-19 | 2,498 | $25.29 | $63.2K | 73,330 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2018-01-17 | 2018-01-19 | 7,990 | $69.95 | $558.9K | 70,832 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2018-01-17 | 2018-01-19 | 21,141 | $68.10 | $1.44M | 78,822 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2018-01-17 | 2018-01-19 | 26,633 | $20.76 | $552.9K | 99,963 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2017-12-18 | 2017-12-20 | 1,816 | $44.96 | $81.6K | 70,832 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | F Tax w/h | 2017-11-08 | 2017-11-09 | 684 | $55.98 | $38.3K | 72,648 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2017-11-02 | 2017-11-03 | 6,666 | — | $0 | 33,334 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2017-11-02 | 2017-11-03 | 6,666 | $25.29 | $168.6K | 79,998 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2017-11-02 | 2017-11-03 | 6,666 | $54.95 | $366.3K | 73,332 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-10-20 | 2017-10-20 | 35,893 | — | $0 | 73,332 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2017-09-13 | 2017-09-14 | 12,850 | $44.95 | $577.6K | 37,439 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2017-08-29 | 2017-08-31 | 12,869 | $39.95 | $514.1K | 50,289 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-06-09 | 2017-06-13 | 13,927 | — | $0 | 13,927 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-04-03 | 2017-04-04 | 12,437 | — | $0 | 12,437 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2017-02-07 | 2017-02-09 | 127,841 | — | $0 | 127,841 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-02-07 | 2017-02-09 | 27,439 | — | $0 | 63,158 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-11-10 | 2016-11-10 | 12,921 | $24.14 | $311.9K | 35,719 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2016-11-08 | 2016-11-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2016-11-08 | 2016-11-10 | 10,000 | — | $0 | 48,640 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2015-11-01 | 2015-11-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2015-11-01 | 2015-11-02 | 38,640 | — | $0 | 38,640 | SEC↗ |